Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus

被引:278
|
作者
Hong Y.-K. [1 ]
Foreman K. [2 ]
Shin J.W. [1 ]
Hirakawa S. [1 ]
Curry C.L. [2 ]
Sage D.R. [3 ]
Libermann T. [4 ]
Dezube B.J. [3 ]
Fingeroth J.D. [3 ]
Detmar M. [1 ]
机构
[1] Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129
[2] Loyola University Medical Center, Maywood
[3] Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
[4] BIDMC Genomics Center, Department of Medicine, Harvard Medical School, Boston
关键词
D O I
10.1038/ng1383
中图分类号
学科分类号
摘要
Kaposi sarcoma is considered a neoplasm of lymphatic endothelium infected with Kaposi sarcoma-associated herpesvirus. It is characterized by the expression of lymphatic lineage-specific genes by Kaposi sarcoma tumor cells. Here we show that infection of differentiated blood vascular endothelial cells with Kaposi sarcoma-associated herpesvirus leads to their lymphatic reprogramming; induction of ∼70% of the main lymphatic lineage-specific genes, including PROX1, a master regulator of lymphatic development; and downregulation of blood vascular genes.
引用
收藏
页码:683 / 685
页数:2
相关论文
共 50 条
  • [21] Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma
    Marcelin, AG
    Gorin, I
    Morand, P
    Ait-Arkoub, Z
    Deleuze, J
    Morini, JP
    Calvez, V
    Dupin, N
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (07) : 704 - 708
  • [22] Vertical transmission of Kaposi's sarcoma-associated herpesvirus
    Mantina, H
    Kankasa, C
    Klaskala, W
    Brayfield, B
    Campbell, J
    Du, QJ
    Bhat, G
    Kasolo, F
    Mitchell, C
    Wood, C
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) : 749 - 752
  • [23] Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)
    Chatlynne, LG
    Ablashi, DV
    SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 175 - 185
  • [24] Immune evasion by Kaposi's sarcoma-associated herpesvirus
    Coscoy, Laurent
    NATURE REVIEWS IMMUNOLOGY, 2007, 7 (05) : 391 - 401
  • [25] Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV)
    Shifflett, Kyle W.
    Dittmer, Dirk P.
    VIROLOGY, 2025, 603
  • [26] RNAs in the virion of Kaposi's sarcoma-associated herpesvirus
    Bechtel, J
    Grundhoff, A
    Ganem, D
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10138 - 10146
  • [27] Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy
    Dittmer, Dirk P.
    Damania, Blossom
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09): : 3165 - 3175
  • [28] Kaposi's sarcoma-associated herpesvirus and extracellular vesicles
    Barrett, Lindsey
    Dai, Lu
    Wang, Shanzhi
    Qin, Zhiqiang
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3294 - 3299
  • [29] Molecular biology of Kaposi's sarcoma-associated herpesvirus
    Cotter, MA
    Robertson, ES
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D358 - D375
  • [30] The molecular pathology of Kaposi's sarcoma-associated herpesvirus
    Jenner, RG
    Boshoff, C
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01): : 1 - 22